Elizabeth Amber, a writer and artist who has cystic fibrosis, had a double-lung and liver transplant in late 2020 at the age of 38. She says she’s always been passionate about personal growth and finding joy no matter the circumstances. She lives in Anchorage, Alaska, with her husband and…
Read more
A lack of stability in a specific region of the CFTR protein may explain why certain people with cystic fibrosis (CF) don’t respond to available modulator therapies, a new study suggests. The findings imply drugs to stabilize this specific region — some of which are already in clinical development…
I felt like I’d received a roundhouse kick to the head while drunk. My head was pounding and I couldn’t think straight. Words were difficult to form. Sentences seemed impossible. This might sound like the result of a wild night of partying, but for me, these were actually signs of…
Two experimental CFTR modulator therapies being developed by Sionna Therapeutics are able to improve the function of the most common mutated form of CFTR protein that causes cystic fibrosis (CF). That’s according to new data Sionna presented at the European Cystic Fibrosis Society (ECFS) 48th European Cystic Fibrosis…
Becoming educated and informed about cystic fibrosis is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your CF journey.
There is no cure for CF yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
